Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technology that allows researchers to analyze the gene expression profiles of individual cells within a tissue or sample. The scRNA-seq solution comprises a combination of laboratory protocols, sequencing platforms, and computational tools specifically designed for the analysis of single-cell transcriptomes.
The global Single Cell RNA Sequencing Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
This report aims to provide a comprehensive presentation of the global market for Single Cell RNA Sequencing Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell RNA Sequencing Solution.
Report Scope
The Single Cell RNA Sequencing Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Cell RNA Sequencing Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cell RNA Sequencing Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type
Equipment
Service
Software
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Cell RNA Sequencing Solution companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell RNA Sequencing Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Service
1.2.4 Software
1.3 Market by Application
1.3.1 Global Single Cell RNA Sequencing Solution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutions
1.3.3 Bioscience Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cell RNA Sequencing Solution Market Perspective (2019-2030)
2.2 Single Cell RNA Sequencing Solution Growth Trends by Region
2.2.1 Global Single Cell RNA Sequencing Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single Cell RNA Sequencing Solution Historic Market Size by Region (2019-2024)
2.2.3 Single Cell RNA Sequencing Solution Forecasted Market Size by Region (2025-2030)
2.3 Single Cell RNA Sequencing Solution Market Dynamics
2.3.1 Single Cell RNA Sequencing Solution Industry Trends
2.3.2 Single Cell RNA Sequencing Solution Market Drivers
2.3.3 Single Cell RNA Sequencing Solution Market Challenges
2.3.4 Single Cell RNA Sequencing Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell RNA Sequencing Solution Players by Revenue
3.1.1 Global Top Single Cell RNA Sequencing Solution Players by Revenue (2019-2024)
3.1.2 Global Single Cell RNA Sequencing Solution Revenue Market Share by Players (2019-2024)
3.2 Global Single Cell RNA Sequencing Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell RNA Sequencing Solution Revenue
3.4 Global Single Cell RNA Sequencing Solution Market Concentration Ratio
3.4.1 Global Single Cell RNA Sequencing Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell RNA Sequencing Solution Revenue in 2023
3.5 Single Cell RNA Sequencing Solution Key Players Head office and Area Served
3.6 Key Players Single Cell RNA Sequencing Solution Product Solution and Service
3.7 Date of Enter into Single Cell RNA Sequencing Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell RNA Sequencing Solution Breakdown Data by Type
4.1 Global Single Cell RNA Sequencing Solution Historic Market Size by Type (2019-2024)
4.2 Global Single Cell RNA Sequencing Solution Forecasted Market Size by Type (2025-2030)
5 Single Cell RNA Sequencing Solution Breakdown Data by Application
5.1 Global Single Cell RNA Sequencing Solution Historic Market Size by Application (2019-2024)
5.2 Global Single Cell RNA Sequencing Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single Cell RNA Sequencing Solution Market Size (2019-2030)
6.2 North America Single Cell RNA Sequencing Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single Cell RNA Sequencing Solution Market Size by Country (2019-2024)
6.4 North America Single Cell RNA Sequencing Solution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cell RNA Sequencing Solution Market Size (2019-2030)
7.2 Europe Single Cell RNA Sequencing Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single Cell RNA Sequencing Solution Market Size by Country (2019-2024)
7.4 Europe Single Cell RNA Sequencing Solution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell RNA Sequencing Solution Market Size (2019-2030)
8.2 Asia-Pacific Single Cell RNA Sequencing Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single Cell RNA Sequencing Solution Market Size by Region (2019-2024)
8.4 Asia-Pacific Single Cell RNA Sequencing Solution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Cell RNA Sequencing Solution Market Size (2019-2030)
9.2 Latin America Single Cell RNA Sequencing Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single Cell RNA Sequencing Solution Market Size by Country (2019-2024)
9.4 Latin America Single Cell RNA Sequencing Solution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell RNA Sequencing Solution Market Size (2019-2030)
10.2 Middle East & Africa Single Cell RNA Sequencing Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single Cell RNA Sequencing Solution Market Size by Country (2019-2024)
10.4 Middle East & Africa Single Cell RNA Sequencing Solution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TAKARA BIO
11.1.1 TAKARA BIO Company Detail
11.1.2 TAKARA BIO Business Overview
11.1.3 TAKARA BIO Single Cell RNA Sequencing Solution Introduction
11.1.4 TAKARA BIO Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.1.5 TAKARA BIO Recent Development
11.2 BioCat GmbH
11.2.1 BioCat GmbH Company Detail
11.2.2 BioCat GmbH Business Overview
11.2.3 BioCat GmbH Single Cell RNA Sequencing Solution Introduction
11.2.4 BioCat GmbH Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.2.5 BioCat GmbH Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Single Cell RNA Sequencing Solution Introduction
11.3.4 Thermo Fisher Scientific Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Detail
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG Single Cell RNA Sequencing Solution Introduction
11.4.4 Roche Holding AG Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.4.5 Roche Holding AG Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Detail
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Single Cell RNA Sequencing Solution Introduction
11.5.4 PerkinElmer Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.5.5 PerkinElmer Recent Development
11.6 Dolomite Bio
11.6.1 Dolomite Bio Company Detail
11.6.2 Dolomite Bio Business Overview
11.6.3 Dolomite Bio Single Cell RNA Sequencing Solution Introduction
11.6.4 Dolomite Bio Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.6.5 Dolomite Bio Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Single Cell RNA Sequencing Solution Introduction
11.7.4 Illumina Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Witec AG
11.8.1 Witec AG Company Detail
11.8.2 Witec AG Business Overview
11.8.3 Witec AG Single Cell RNA Sequencing Solution Introduction
11.8.4 Witec AG Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.8.5 Witec AG Recent Development
11.9 10x Genomics, Inc
11.9.1 10x Genomics, Inc Company Detail
11.9.2 10x Genomics, Inc Business Overview
11.9.3 10x Genomics, Inc Single Cell RNA Sequencing Solution Introduction
11.9.4 10x Genomics, Inc Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.9.5 10x Genomics, Inc Recent Development
11.10 Oxford Nanopore Technologies
11.10.1 Oxford Nanopore Technologies Company Detail
11.10.2 Oxford Nanopore Technologies Business Overview
11.10.3 Oxford Nanopore Technologies Single Cell RNA Sequencing Solution Introduction
11.10.4 Oxford Nanopore Technologies Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.10.5 Oxford Nanopore Technologies Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Single Cell RNA Sequencing Solution Introduction
11.11.4 QIAGEN Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.11.5 QIAGEN Recent Development
11.12 LC Sciences
11.12.1 LC Sciences Company Detail
11.12.2 LC Sciences Business Overview
11.12.3 LC Sciences Single Cell RNA Sequencing Solution Introduction
11.12.4 LC Sciences Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.12.5 LC Sciences Recent Development
11.13 Pacific Biosciences
11.13.1 Pacific Biosciences Company Detail
11.13.2 Pacific Biosciences Business Overview
11.13.3 Pacific Biosciences Single Cell RNA Sequencing Solution Introduction
11.13.4 Pacific Biosciences Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.13.5 Pacific Biosciences Recent Development
11.14 Scipio bioscience
11.14.1 Scipio bioscience Company Detail
11.14.2 Scipio bioscience Business Overview
11.14.3 Scipio bioscience Single Cell RNA Sequencing Solution Introduction
11.14.4 Scipio bioscience Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.14.5 Scipio bioscience Recent Development
11.15 CD Genomics
11.15.1 CD Genomics Company Detail
11.15.2 CD Genomics Business Overview
11.15.3 CD Genomics Single Cell RNA Sequencing Solution Introduction
11.15.4 CD Genomics Revenue in Single Cell RNA Sequencing Solution Business (2019-2024)
11.15.5 CD Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
听
听
*If Applicable.
